The Protection Gap - Diagnosis, Treatment Status, and Disease Control for People with Diabetes and Hypertension in the US-Affiliated Pacific Islands.

Q4 Medicine
A Mark Durand, Haley L Cash, Martina L E Reichhardt, Livinson Taulung, Nena M Tolenoa
{"title":"The Protection Gap - Diagnosis, Treatment Status, and Disease Control for People with Diabetes and Hypertension in the US-Affiliated Pacific Islands.","authors":"A Mark Durand,&nbsp;Haley L Cash,&nbsp;Martina L E Reichhardt,&nbsp;Livinson Taulung,&nbsp;Nena M Tolenoa","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Hypertension and diabetes are major causes of disability and mortality in the US-Affiliated Pacific Islands (USAPI). Control of these conditions has the potential to avert much of the burden of non-communicable diseases in the region. To realize this potential, people living with hypertension and diabetes must be identified and receive treatment of sufficient intensity to control their blood pressure and blood glucose. Data from recent cross-sectional surveys conducted in 5 jurisdictions-Pohnpei, Palau, Kosrae, Marshall Islands and American Samoa-were used to estimate the adult prevalence of hypertension and diabetes as well as diagnosis awareness, treatment, and control status of the adults with these conditions. In addition to traditional prevalence indicators, the authors provide a novel presentation of non-communicable disease (NCD) data, using the concept of \"protection gaps\", defined as the number of people living in a community who have an NCD for which effective control is not attained. The protection gap is determined by applying survey-derived population prevalence estimates to the community's population size using census data. The protection gap is further divided into 3 groups: (1) case-finding gap-those who are unaware of their conditions; (2) tracking and outreach gap-those who are aware of their condition but not receiving treatment; and (3) treatment efficacy gap-those who are receiving treatment but whose disease is not under control. The findings show a large protection gap, with a majority of adults living with hypertension (80.8%) and diabetes (91.6%) not having their condition under control. The case-finding gap accounts for more than half of these, followed by treatment efficacy, and tracking and outreach gaps. These findings can guide public health strategies and monitoring for control of hypertension and diabetes in the USAPI region.</p>","PeriodicalId":36659,"journal":{"name":"Hawai''i journal of health & social welfare","volume":"82 3","pages":"66-71"},"PeriodicalIF":0.0000,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9995153/pdf/hjhsw8203_0066.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hawai''i journal of health & social welfare","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Hypertension and diabetes are major causes of disability and mortality in the US-Affiliated Pacific Islands (USAPI). Control of these conditions has the potential to avert much of the burden of non-communicable diseases in the region. To realize this potential, people living with hypertension and diabetes must be identified and receive treatment of sufficient intensity to control their blood pressure and blood glucose. Data from recent cross-sectional surveys conducted in 5 jurisdictions-Pohnpei, Palau, Kosrae, Marshall Islands and American Samoa-were used to estimate the adult prevalence of hypertension and diabetes as well as diagnosis awareness, treatment, and control status of the adults with these conditions. In addition to traditional prevalence indicators, the authors provide a novel presentation of non-communicable disease (NCD) data, using the concept of "protection gaps", defined as the number of people living in a community who have an NCD for which effective control is not attained. The protection gap is determined by applying survey-derived population prevalence estimates to the community's population size using census data. The protection gap is further divided into 3 groups: (1) case-finding gap-those who are unaware of their conditions; (2) tracking and outreach gap-those who are aware of their condition but not receiving treatment; and (3) treatment efficacy gap-those who are receiving treatment but whose disease is not under control. The findings show a large protection gap, with a majority of adults living with hypertension (80.8%) and diabetes (91.6%) not having their condition under control. The case-finding gap accounts for more than half of these, followed by treatment efficacy, and tracking and outreach gaps. These findings can guide public health strategies and monitoring for control of hypertension and diabetes in the USAPI region.

保护差距——美国附属太平洋岛屿糖尿病和高血压患者的诊断、治疗状况和疾病控制。
高血压和糖尿病是美国附属太平洋岛屿(USAPI)致残和死亡的主要原因。控制这些疾病有可能在很大程度上避免该区域的非传染性疾病负担。为了实现这一潜力,必须识别高血压和糖尿病患者并接受足够强度的治疗,以控制他们的血压和血糖。最近在5个辖区(波纳佩、帕劳、科斯雷、马绍尔群岛和美属萨摩亚)进行的横断面调查数据用于估计高血压和糖尿病的成人患病率以及患有这些疾病的成年人的诊断意识、治疗和控制状况。除了传统的流行率指标外,作者还提出了一种非传染性疾病(NCD)数据的新表达方式,使用了"保护差距"的概念,其定义为生活在一个社区中患有非传染性疾病但未得到有效控制的人数。保护缺口是通过使用普查数据将调查得出的人口流行率估计值应用于社区人口规模来确定的。保护缺口进一步分为三类:(1)病例发现缺口——那些不知道自己病情的人;(2)跟踪和外展差距——那些知道自己的病情但没有接受治疗的人;(3)治疗效果缺口——正在接受治疗但疾病未得到控制的患者。调查结果显示存在很大的保护差距,大多数患有高血压(80.8%)和糖尿病(91.6%)的成年人的病情没有得到控制。病例发现方面的差距占其中的一半以上,其次是治疗效果方面的差距,以及跟踪和外联方面的差距。这些发现可以指导USAPI地区高血压和糖尿病控制的公共卫生策略和监测。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
1.50
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信